OGT-mediated O-GlcNAcylation stabilizes EGR1 to drive vascular leakage in acute respiratory distress syndrome
Life Sciences · 2026-12 · 407 · 124753
DOI: 10.1016/j.lfs.2026.124753 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026-12. Verfasst von Fan Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330009, China. Hauptthemen laut MEDLINE: Early Growth Response Protein 1, Capillary Permeability, Respiratory Distress Syndrome, N-Acetylglucosaminyltransferases. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
AIMS: Increased vascular permeability is a hallmark of acute respiratory distress syndrome (ARDS), yet the molecular mechanisms underlying this process remain poorly understood. MATERIALS AND METHODS: An ARDS mouse model was established by intratracheal instillation of LPS. Proteomic analysis was performed to identify differentially expressed proteins. Protein and gene expression were assessed by western blotting and RT-qPCR. Immunoprecipitation, mass spectrometry, mutagenesis, ubiquitination, and O-GlcNAcylation assays were employed to investigate the underlying molecular mechanisms. KEY FINDINGS: We identified O-GlcNAc transferase (OGT) as a critical regulator of endothelial barrier dysfunction in ARDS. Proteomic profiling of alveolar endothelial cells isolated from LPS-induced ARDS mice revealed marked upregulation of OGT and the transcription factor early growth response 1 (EGR1). Mechanistically, OGT directly O-GlcNAcylates EGR1 at threonine 329, preventing RNF5 (Ring Finger Protein 5)-mediated ubiquitination and proteasomal degradation and thereby stabilizing EGR1 under inflammatory conditions. Stabilized EGR1 subsequently associates with the transcriptional coactivators CBP (CREB-binding protein) and PCAF (p300/CBP-associated factor) to form a functional complex that binds the promoters of vascular permeability-related genes, including VEGFA (vascular endothelial growth factor A), ANGPT2 (angiopoietin 2), ICAM1 (intercellular adhesion molecule 1), and MMP9 (matrix metallopeptidase 9), thereby promoting their transcription. Pharmacological inhibition of OGT markedly reduced EGR1 stabilization, suppressed permeability-associated gene expression, and significantly attenuated vascular leakage in ARDS mice. SIGNIFICANCE: These findings reveal a previously unrecognized OGT-EGR1-CBP/PCAF signaling axis that drives endothelial barrier dysfunction in ARDS and highlight potential therapeutic targets for this life-threatening disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330009, China.
- Department of Emergency, Huadong Hospital, Fudan University, Shanghai, 200040, China.
- Department of Emergency, Huadong Hospital, Fudan University, Shanghai, 200040, China; Department of Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China. Electronic add…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, F., Yan, W., Zhou, W., & Chen, Z. (2026). OGT-mediated O-GlcNAcylation stabilizes EGR1 to drive vascular leakage in acute respiratory distress syndrome. Life Sciences, 407, 124753. https://doi.org/10.1016/j.lfs.2026.124753
Vancouver
Li F, Yan W, Zhou W, Chen Z. OGT-mediated O-GlcNAcylation stabilizes EGR1 to drive vascular leakage in acute respiratory distress syndrome. Life Sciences. 2026;407:124753. doi:10.1016/j.lfs.2026.124753
BibTeX
@article{Li2026,
author = {Li, Fan and Yan, Wenqing and Zhou, Wenqiang and Chen, Zhi},
title = {OGT-mediated O-GlcNAcylation stabilizes EGR1 to drive vascular leakage in acute respiratory distress syndrome},
journal = {Life Sciences},
year = {2026},
volume = {407},
pages = {124753},
doi = {10.1016/j.lfs.2026.124753}
}
EUVIMED